Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus

Stopped The PDA patients have vanished. The last recruitment took place in 2022. In the joint discussion of the principal researchers, it was concluded that PDA patients no longer have to be treated in Finland and the study was terminated.

Conditions

• Patent Ductus Arteriosus

Interventions

• DRUG: Paracetamol 10Mg/mL
• DRUG: 0.45% Sodium Chloride
• DRUG: Ibuprofen
• DRUG: Indomethacin

Sponsor

University of Oulu

Collaborators

• [object Object]
• [object Object]
• [object Object]